Skip to main content
. 2014 Jul 22;12:116. doi: 10.1186/s12955-014-0116-1

Table 2.

Content validity of patient-reported outcome measure ~

Concept identified in literature review
SLE-specific HRQoL
Generic HRQoL
Fatigue
Pain
Depression
Work
  SLAQ LupusQoL $ LupusPRO $ L-QoL SLEQOL SF-36v2 EQ-5D # FACIT-Fatigue MFI MAF MPQ BPI-SF BDI HADS WPAI: Lupus
Disease-defining signs and symptoms
Marks on skin

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weight gain/bloating


 
 
 
 
 
 
 
 
 
 
 
 
 
Hair loss



 
 
 
 
 
 
 
 
 
 
 
 
Looking sick
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reduced cognitive function



 

 
 
 

 
 
 
 
 
 
Fatigue






 
✓*
✓*
✓*
 
 

 
 
Pain

 

 



 
 
 


 
 
 
Fever

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weakness
 
 
 
 
 

 
✓*
✓*
 
 
 
 
 
 
Flu-like symptoms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Impacts
Physical functioning
 


 



 
✓*
✓*
 
✓*
 
 
 
Daily activities
 






✓*
✓*
✓*
 
✓*
 
 

Sleep problems
 

 
 
 

 
✓*
✓* (p)
 
 
✓*
 
 
 
Emotional/Psychological







✓*
 
✓* (p)
 
✓*


 
Social functioning
 

 



 
✓*
✓* (p)
✓*
 
 
 
 
 
Leisure activities
 

 
 


 
 
✓*
✓*
 
 
 
 
 
Relationships
 

 

 

 
 
 
✓ (p)
 
✓*
 
 
 
Work & economic impacts
Work disability
 
 

 


 
 
 
✓*
 
✓*
 
 

Economic impact
 
 

 


 
 
 
 
 
 
 
 
 
Total 8/27 11/27 9/27 5/27 10/27 12/27 4/27 6/27 8/27 8/27 1/27 7/27 2/27 1/27 2/27

SLAQ – Systemic Lupus Activity Questionnaire, SF-36v2 – Short Form [36] Health Survey, EQ-5D – EuroQol 5-Dimensions, FACIT-Fatigue - Functional Assessment of Chronic Illness Therapy, MFI – Multidimensional Fatigue Inventory, MAF – Multidimensional Assessment of Fatigue, MGQ – McGill Pain Scale, BPI – Brief Pain Inventory, BDI – Beck Depression Inventory, HADS – Hospital Anxiety and Depression Scale, WPAI:Lupus – Work Productivity and Activity Impairment Questionnaire: Lupus.

~ The following symptoms were identified as important in the literature review, but are not measured by current PROs: flu-like symptoms, dry mouth, skin rash, speech problems, vision sensitivity to bright lights, sensitivity to hot/cold temperatures, reduced hand grip, haematological abnormalities, sleep related respiratory and movement problems $PRO measure has documented evidence of qualitative research with patients with SLE during item generation #Result valid for both the EQ-5D-3L and EQ-5D-5L *Concept assessed only as a fatigue related impact (p) Concept partially covered by one or more items.